NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
209 hedge funds and large institutions have $2.95B invested in NEVRO CORP. in 2021 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 79 increasing their positions, 58 reducing their positions, and 25 closing their positions.
72% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 25
36% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 58
8% more funds holding
Funds holding: 194 → 209 (+15)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
27% less call options, than puts
Call options by funds: $25.2M | Put options by funds: $34.3M
32% less capital invested
Capital invested by funds: $4.37B → $2.95B (-$1.41B)
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$84.5M |
| 2 |
Two Sigma Investments
New York
|
+$41.5M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$30.9M |
| 4 |
DM
Deerfield Management
New York
|
+$21.6M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$21.4M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$235M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$40.7M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
-$38.7M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$37.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$37.5M |
NVRO Hedge Fund Activity: Q4 2021 in Review
209 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q4 2021, worth a combined $2.95B — down 32% from $4.37B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new NVRO positions and 25 closed out — a net gain of 18 holders — while 79 added to existing stakes and 58 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $84.5M. The largest seller was T. Rowe Price Associates, cutting an estimated $235M.
- 209 institutional investors held NEVRO CORP. (NVRO) as of Q4 2021, up from 194 in Q3 2021.
- Funds reported $2.95B of NEVRO CORP. stock for Q4 2021, down 32% quarter-over-quarter.
- 43 funds opened new NEVRO CORP. positions in Q4 2021 and 25 closed out, a net change of +18 holders.
- The largest NEVRO CORP. buyer in Q4 2021 was Wellington Management Group, an estimated $84.5M added.
- The largest NEVRO CORP. seller in Q4 2021 was T. Rowe Price Associates, an estimated $235M sold.
Based on aggregated 13F filings for Q4 2021.